• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科药物在其理化性质方面与食物和饮料共同给药-全球范围内的实践和建议。

Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations.

机构信息

Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, UK.

Pharmaceutical Technology and Development, Astra Zeneca, Macclesfield, UK.

出版信息

AAPS J. 2020 Mar 4;22(2):54. doi: 10.1208/s12248-020-0432-9.

DOI:10.1208/s12248-020-0432-9
PMID:32133550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7056676/
Abstract

Medicine co-administration with food or drink vehicles is a common administration practice in paediatrics. The aims of this review were (i) to describe the current recommended strategies for co-administration of paediatric medicines with food and drinks (vehicles); (ii) to compare current administration recommendations from different countries; and (iii) to obtain a global perspective on the rationale behind the choice of recommended vehicle, in the context of the physicochemical properties of the drug and formulation. This study used a defined search strategy on the practices of paediatric medicine co-administration with vehicles, recommended in a commonly used paediatric and neonatal handbook, in addition to the information previously gathered from UK formularies. Logistic regression analysis was performed to further understand the biopharmaceutical basis of the choice of recommended vehicle for medicine co-administration. Differences were identified in the type of vehicles globally recommended for medicine co-administration. Ultimately, a statistical model was developed which provided an understanding on which vehicle is recommended for use with drugs/formulations, with basis on their biopharmaceutical properties. Overall, this review highlights the areas where further information is needed to support standardised procedures and guide the recommendation of age-appropriate and acceptable vehicles for use in the co-administration of paediatric medicines. Unified requirements are needed for harmonisation of the practice of medicine co-administration with vehicles. In vitro and/or in silico tools should be developed to evaluate the potential clinical outcomes of this practice during paediatric drug development.

摘要

将药物与食物或饮料载体共同给药是儿科中的常见给药方法。本综述的目的是:(i) 描述目前推荐的儿科药物与食物和饮料(载体)共同给药的策略;(ii) 比较不同国家的现行给药建议;以及 (iii) 在药物和制剂的理化性质背景下,从全球角度了解推荐载体选择背后的原理。本研究使用了一种定义明确的搜索策略,针对常用儿科和新生儿手册中推荐的儿科药物与载体共同给药的实践,以及之前从英国处方集收集的信息。进行了逻辑回归分析,以进一步了解药物共同给药时推荐载体选择的生物制药基础。在全球范围内,推荐用于药物共同给药的载体类型存在差异。最终,开发了一个统计模型,该模型基于药物/制剂的生物制药特性,了解了推荐使用哪种载体与药物共同给药。总的来说,本综述强调了需要进一步信息的领域,以支持标准化程序并指导推荐适合儿科药物共同给药的年龄适宜和可接受的载体。需要统一的要求来协调药物与载体共同给药的实践。应开发体外和/或计算工具,以在儿科药物开发期间评估这种给药实践的潜在临床结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/0666b176f925/12248_2020_432_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/ac8e5faf6373/12248_2020_432_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/19415c185c0d/12248_2020_432_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/164342acd77f/12248_2020_432_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/2fb47c744afe/12248_2020_432_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/0666b176f925/12248_2020_432_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/ac8e5faf6373/12248_2020_432_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/19415c185c0d/12248_2020_432_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/164342acd77f/12248_2020_432_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/2fb47c744afe/12248_2020_432_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530d/7056676/0666b176f925/12248_2020_432_Fig5_HTML.jpg

相似文献

1
Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations.儿科药物在其理化性质方面与食物和饮料共同给药-全球范围内的实践和建议。
AAPS J. 2020 Mar 4;22(2):54. doi: 10.1208/s12248-020-0432-9.
2
Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review.基于儿科药物生物药剂学特性,关于与食物和饮料一起口服给药的推荐策略:综述
J Pharm Pharmacol. 2017 Apr;69(4):384-397. doi: 10.1111/jphp.12635. Epub 2016 Oct 5.
3
Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance: Part 1-Effects on Solubility of Poorly Soluble Drugs.食品和饮料管理车辆对儿科配方性能的影响:第 1 部分-对难溶性药物溶解度的影响。
AAPS PharmSciTech. 2020 Jun 26;21(5):177. doi: 10.1208/s12249-020-01722-z.
4
Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance Part 2: Dissolution of Montelukast Sodium and Mesalazine Formulations.食品和饮料管理车辆对儿科配方性能的影响 第 2 部分:孟鲁司特钠和美沙拉嗪配方的溶解。
AAPS PharmSciTech. 2020 Oct 15;21(7):287. doi: 10.1208/s12249-020-01815-9.
5
In Vivo Predictive Dissolution Testing of Montelukast Sodium Formulations Administered with Drinks and Soft Foods to Infants.婴儿服用饮料和软食时给予的孟鲁司特钠制剂的体内预测溶出度测试。
AAPS PharmSciTech. 2020 Oct 13;21(7):282. doi: 10.1208/s12249-020-01825-7.
6
Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children.在给儿童给药前常与口服药物制剂混合的液体和软质食物的物理化学特性。
Pharmazie. 2016 Mar;71(3):122-7.
7
Food effects in paediatric medicines development for products Co-administered with food.儿童药品开发中与食物共同给予的产品的食物影响。
Int J Pharm. 2018 Feb 5;536(2):530-535. doi: 10.1016/j.ijpharm.2017.05.011. Epub 2017 May 8.
8
Evidence of acceptability of oral paediatric medicines: a review.口服儿科药物可接受性的证据:一项综述。
J Pharm Pharmacol. 2017 Apr;69(4):361-376. doi: 10.1111/jphp.12610. Epub 2016 Aug 14.
9
Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.儿科人群中使用非口服制剂的障碍:一项半结构化访谈研究。
Int J Pharm. 2016 Jan 30;497(1-2):12-7. doi: 10.1016/j.ijpharm.2015.11.010. Epub 2015 Nov 28.
10
Best practices for selection of excipients for paediatrics - Workshop reflection.辅料选择的最佳实践 - 专题研讨会反思。
Eur J Pharm Biopharm. 2021 Mar;160:77-81. doi: 10.1016/j.ejpb.2020.12.021. Epub 2021 Jan 2.

引用本文的文献

1
Poor-tasting pediatric medicines: part 2. Exploring caregiver and healthcare provider values and preferences for a novel taste-blocker product to improve acceptability.口感不佳的儿科药物:第2部分。探索护理人员和医疗服务提供者对新型味觉阻滞剂产品的价值观和偏好,以提高可接受性。
Front Drug Deliv. 2025 Apr 22;5:1555522. doi: 10.3389/fddev.2025.1555522. eCollection 2025.
2
The Past, Present, and Future of Oral Dosage Forms for Children.儿童口服剂型的过去、现在与未来
J Pediatr Pharmacol Ther. 2024;29(1):22-31. doi: 10.5863/1551-6776-29.1.22. Epub 2024 Feb 7.
3
Dispensing Oral Temozolomide in Children: Precision and Stability of a Novel and Ready to Use Liquid Formulation in Comparison with Capsule Derived Mixtures.

本文引用的文献

1
Manipulation of oral medication for children by parents and nurses occurs frequently and is often not supported by instructions.家长和护士经常会自行给儿童喂药,而这种情况往往没有得到用药说明的支持。
Acta Paediatr. 2019 Aug;108(8):1475-1481. doi: 10.1111/apa.14718. Epub 2019 Mar 13.
2
Evaluation of patient-reported outcome measurements as a reliable tool to measure acceptability of the taste of paediatric medicines in an inpatient paediatric population.评估患者报告的结局测量指标作为衡量住院儿科患者群体中儿科药物口味可接受性的可靠工具。
BMJ Open. 2018 Jul 11;8(7):e021961. doi: 10.1136/bmjopen-2018-021961.
3
Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products - a PEARRL review.
儿童口服替莫唑胺的配药:一种新型即用型液体制剂与胶囊衍生混合物相比的精准度和稳定性
Pharmaceutics. 2023 Nov 30;15(12):2711. doi: 10.3390/pharmaceutics15122711.
4
Nurses' knowledge and practice regarding mixing medications with food: a multicenter cross-sectional study from a developing country.护士关于将药物与食物混合的知识和实践:来自发展中国家的一项多中心横断面研究。
J Health Popul Nutr. 2023 Jun 5;42(1):52. doi: 10.1186/s41043-023-00396-0.
5
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool.评估世界卫生组织儿童基本药物示范清单上制剂的适宜性:儿科质量目标产品简介工具的开发
Pharmaceutics. 2022 Feb 22;14(3):473. doi: 10.3390/pharmaceutics14030473.
6
Evaluating the Taste Masking Ability of Two Novel Dispersible Tablet Platforms Containing Zinc Sulfate and Paracetamol Reconstituted in a Breast Milk Substitute.评估两种新型分散片剂平台在母乳替代品中重构的含硫酸锌和对乙酰氨基酚制剂的掩味能力。
Pharmaceutics. 2022 Feb 15;14(2):420. doi: 10.3390/pharmaceutics14020420.
7
Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions.孟鲁司特儿科制剂的性能评价:第一部分——与年龄相关的体外条件。
AAPS J. 2022 Jan 10;24(1):26. doi: 10.1208/s12248-021-00661-2.
8
Performance Evaluation of Montelukast Pediatric Formulations: Part II - a PBPK Modelling Approach.孟鲁司特儿科制剂的性能评估:第二部分-基于 PBPK 的建模方法。
AAPS J. 2022 Jan 10;24(1):27. doi: 10.1208/s12248-021-00662-1.
儿科生物制药考量因素,旨在评估口服药物产品 - PEARRL 综述。
J Pharm Pharmacol. 2019 Apr;71(4):603-642. doi: 10.1111/jphp.12955. Epub 2018 Jul 3.
4
Food effects in paediatric medicines development for products Co-administered with food.儿童药品开发中与食物共同给予的产品的食物影响。
Int J Pharm. 2018 Feb 5;536(2):530-535. doi: 10.1016/j.ijpharm.2017.05.011. Epub 2017 May 8.
5
A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice.系统评价剂量形式调整在获得所需剂量以告知儿科实践中使用调整的应用。
Int J Pharm. 2017 Feb 25;518(1-2):155-166. doi: 10.1016/j.ijpharm.2016.12.032. Epub 2016 Dec 28.
6
Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review.基于儿科药物生物药剂学特性,关于与食物和饮料一起口服给药的推荐策略:综述
J Pharm Pharmacol. 2017 Apr;69(4):384-397. doi: 10.1111/jphp.12635. Epub 2016 Oct 5.
7
Evidence of acceptability of oral paediatric medicines: a review.口服儿科药物可接受性的证据:一项综述。
J Pharm Pharmacol. 2017 Apr;69(4):361-376. doi: 10.1111/jphp.12610. Epub 2016 Aug 14.
8
Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children.在给儿童给药前常与口服药物制剂混合的液体和软质食物的物理化学特性。
Pharmazie. 2016 Mar;71(3):122-7.
9
Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.给儿童开的口服制剂存在的问题:医疗保健专业人员焦点小组研究
Int J Clin Pharm. 2015 Dec;37(6):1057-67. doi: 10.1007/s11096-015-0152-x. Epub 2015 Jul 15.
10
Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.确定影响居家儿科人群口服药物可接受性的配方因素。
Int J Pharm. 2015 Mar 1;480(1-2):55-62. doi: 10.1016/j.ijpharm.2015.01.023. Epub 2015 Jan 16.